Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × lenvatinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 11 Carcinoma, Renal Cell 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Liver Neoplasms 3 Neoplasms 2 Endometrial Neoplasms 2 Biliary Tract Neoplasms 2 von Hippel-Lindau Disease 1 Vulvar Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer 1 Hematologic Neoplasms 1 GIST 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Malignancies 1

Interventions

ruxolitinib 6 fludarabine 6 Specimen Handling 6 fludarabine phosphate 4 Whole-Body Irradiation 4 Cyclophosphamide 4 Biopsy 4 Azacitidine 4 venetoclax 3 decitabine and cedazuridine drug combination 3 Mycophenolic Acid 3 Melphalan 3 Cytarabine 3 Busulfan 3 Tacrolimus 2 Stem Cell Transplantation 2 Sirolimus 2 Liposomes 2 Injections 2 Granulocyte Colony-Stimulating Factor 2 Daunorubicin 2 CPX-351 2 selinexor 1 quizartinib 1 plerixafor 1 pegylated granulocyte colony-stimulating factor 1 olutasidenib 1 luspatercept 1 letermovir 1 iadademstat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡